Why Doctors Should Consider Prescribing Generic Drugs for Better Healthcare

Healthcare costs continue to rise globally, placing increasing financial strain on patients and healthcare systems alike. In India, generic medicines help reduce out-of-pocket costs. Schemes like the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana offer medicines at 50–80% lower prices than branded alternatives, resulting in substantial savings for patients^[1]. Despite these substantial benefits, around 2 billion people globally still lack access to essential medicines, particularly in lower- and middle-income countries^[2]. In India, the Medical Council regulations since 2002 have encouraged physicians to prescribe drugs using generic names to ensure rational prescription practices^[3].

Understanding why doctors should consider prescribing generic medicines may enhance patient outcomes by improving adherence.

Why Doctors Should Consider Prescribing Generic Drugs?

When doctors prescribe generic medicines instead of their branded equivalents, they enable several significant benefits that extend beyond individual patients to impact the entire healthcare system.

Affordability for Patients

Generic medicines offer substantially lower prices compared to their branded counterparts while maintaining equivalent therapeutic effects. These medicines are similar to branded medicines in terms of active ingredient, dosage, and therapeutic effects; however, they can be 20-90% cheaper^[4]. This makes generics significantly more affordable for patients across all income levels.

In India specifically, the price difference is remarkable. A recent citizen-funded study revealed that branded drugs averaged Rs 11.17 per tablet, whereas Jan Aushadhi generics cost just Rs 2.40 on average, making generics 78.5% cheaper overall. Some medicines show even more dramatic differences. For example, pantoprazole costs 14 times more in the branded form^[5].

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) demonstrates the real-world impact of generic medicine adoption. In FY24, PMBJP made sales of Rs 1,470 crore at MRP, leading to savings of approximately Rs 7,350 crore for citizens. Additionally, over the past decade, this scheme has generated total savings of approximately Rs 30,000 crores for Indian patients^[6].

Medication decisions should always be made in consultation with your healthcare provider based on your individual health needs.

Equivalent Therapeutic Effect and Safety Standards

Generic medicines can provide the same therapeutic benefits as their branded versions because they must meet stringent regulatory standards for bioequivalence. Generic medicines are considered clinically interchangeable in most cases and must meet the same quality, efficacy, and safety standards^[7].

Regulatory authorities worldwide enforce strict bioequivalence requirements. The US Food and Drug Administration requires that the 90% confidence interval of the pharmacokinetic ratio should lie between 0.80 and 1.25^[8]. This means the 90% confidence interval of the ratio of pharmacokinetic parameters must fall within 80% to 125% of the reference product.

India has also implemented rigorous standards. Since 2016, India has established bioequivalence guidelines requiring that the 90% confidence interval for the ratio of key pharmacokinetic parameters (such as Cmax and AUC) between a generic medicine and its branded version must fall within the acceptable range of 80% to 125%^[9]. These guidelines ensure that generic medicines available in India meet international quality standards.

The recent citizen-funded study in India further validated these standards, demonstrating that generic medicines match the quality of branded medicines in actual testing^[5].

Improved Treatment Adherence

Medication adherence remains a critical challenge in healthcare. Research indicates that adherence rates for chronic therapies in India are low (often below 25 %) and that poor adherence is linked with increased complications and higher healthcare costs, including substantial out-of-pocket expenses for hospital readmissions^[10]. Cost represents a major barrier to consistent medication use.

Research consistently shows that decreasing patient out-of-pocket medication costs through generic substitution can increase medication adherence^[11]. When patients can afford their medications, they are more likely to take them as prescribed, leading to better health outcomes and fewer complications.

Generic medicine policies have proven effective in lowering costs and expanding access, especially for low-income patients. By prescribing generic medicines, doctors can help address medication non-adherence caused by financial constraints^[12].

Wider Accessibility and Healthcare System Impact

Generic medicines significantly expand access to essential treatments. Research indicates that switching procurement from innovator brands to the lowest priced generic equivalents in the private sector in 17 developing countries could result in an average of 60% cost savings^[7], dramatically improving access to essential medicines.

India has made substantial infrastructure investments to improve generic medicine accessibility. Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, a total of 16,912 Jan Aushadhi Kendras have been opened till June 2025, with the government deciding to increase this to 20,000 by March 2026^[1].

This expansion brings affordable generic medicines within reach of millions of additional patients across the country. However, significant room for improvement remains. A multicentric study across Indian tertiary care hospitals conducted by ICMR Rational Use of Medicines centres found that generic drugs were prescribed in only 47.58% of prescriptions^[13]. Increasing this percentage could substantially improve healthcare affordability and access nationwide.

The broader benefits to the healthcare system are substantial. Since 2016, generic drugs have steadily made up 9 out of every 10 prescriptions filled in the US, while their overall percentage of costs declined from 27 percent in 2016 to only 12 percent in 2024^[14]. This demonstrates how widespread generic adoption improves healthcare system efficiency without compromising patient care.

Conclusion

Encouraging doctors to prescribe generic drugs represents a practical approach to making healthcare more affordable, accessible, and sustainable while maintaining safety and effectiveness. Generic medicines offer 20-90% cost savings, depending on the medicine and market, compared to their branded equivalents. They meet the same rigorous bioequivalence standards, improve treatment adherence by reducing financial barriers, and expand access to essential medicines for millions of patients.

With India's regulatory framework supporting generic medicine prescription and infrastructure like Jan Aushadhi Kendras expanding nationwide, doctors have both the authority and the resources to make generic prescribing a standard practice. By considering generic alternatives whenever clinically appropriate, physicians can play a crucial role in building a more equitable and sustainable healthcare system.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating health conditions. Always consult a qualified healthcare provider for diagnosis, treatment, and personalised medical advice. Do not disregard professional medical advice or delay seeking it because of information found in this article. If you have a medical emergency, contact your doctor or emergency services immediately.